Mandate

Vinge advises Carnegie in connection with the acquisition of Erik Penser Bank’s securities business

Vinge has advised Carnegie Investment Bank AB in connection with the acquisition of the business sectors Erik Penser Wealth Management and Erik Penser Corporate Finance as well as the analytical services Penser Access and Penser Future from Erik Penser Bank AB. The consideration for the completed purchase consists of shares in Carnegie and the acquisition is subject to customary conditions from public authorities.

Carnegie Group is currently the Nordic region’s leading financial adviser and asset manager with 800 employees in six countries. Erik Penser Bank offers an extensive portfolio of financial services and was founded through the establishment of Erik Penser Fondkommission in 1994 by Erik Penser.

Vinge’s team primarily consisted of Kristian Ford (responsible partner), Sofie Nordgren, Anna Edström, Henrik Borna and Agaton Lindgren (M&A), Nils Unckel, Anton Sjökvist and Viktoria Wnuk (regulatory), Pär Remnelid (competition), Emelie Svensäter Jerntorp (employment), Lisa Bourghardt (IP), Fredrik Christiansson (banking and finance) and Ulf Nilsson (tax).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025